NeuroXT and BIDMC Expand Collaboration to Advance AI-Driven Precision Treatment in Alzheimer's Disease

The Aspen Group Named a 2026 Top Workplaces Winner for Culture and Excellence in Three Categories

Precigen to Participate in Fireside Chats with J.P. Morgan and at the Goldman Sachs 47th Annual Global Healthcare Conference

PBM Reform Raises Employer Oversight Pressure Before Final Rules Are Settled

Mounting Rx Lawsuits Expose Ongoing Concerns Over FDA's Revolving Door

Virax Biolabs Reports Positive Early Clinical Data for ViraxImmune™ in Long COVID and Related Post-Acute Infection Syndromes

Biohaven Reports New Clinical Data in Epilepsy with Opakalim, a Selective Kv7.2/7.3 Activator, Highlighting Seizure Control and Markedly Differentiated Tolerability Profile

Kazia Therapeutics Expands Ongoing Phase 1b Trial of Paxalisib in Advanced Breast Cancer

Adcendo ApS Announces Clinical Collaboration and Supply Agreement with MSD to Evaluate ADCE-T02 in Combination with KEYTRUDA® (Pembrolizumab) in a Phase Ib Study in Patients with Advanced Solid Tumors

Lilly announces three acquisitions to build infectious disease portfolio

Vaccine Company to be acquired by Lilly to advance best-in-class vaccine candidates for Epstein-Barr Virus and other infectious diseases

Koya Medical to Attend June 2026 Investor Conferences

ZETA SURGICAL Announces First Commercial Deployment of Zeta TMS Navigation System at HOPE Therapeutics

IDEAYA Biosciences Announces Participation at the 2026 Jefferies Global Healthcare Conference

Astellas Announces Five-Year Corporate Strategic Plan to Deliver Greater VALUE Faster for Patients and Position Itself as a Sustainable Growth Company

Lundbeck receives marketing authorization for Vyepti® (eptinezumab) in South Korea for the preventive treatment of migraine

Over 40 Studies Featuring Akeso's Innovative Oncology Agents to Be Presented at ASCO 2026: Ivonescimab's HARMONi-6 Overall Survival Data Selected for Plenary Session

WuXi Vaccines' Drug Substance Facility Receives Brazil ANVISA GMP Certification for Dengue Vaccine Manufacturing

Yili Unveils Global Innovation Vanguard Initiative in Cambridge, UK

MAHA ACTION WELCOMES BIOTECH PIONEER LOU REESE TO ITS BOARD OF DIRECTORS

Nuvation Bio Announces IBTROZI® (Taletrectinib) Showed Highly Durable Responses in Longer-Term Follow-up Data from Pivotal Studies Presented at AACR 2026

SLNO Investor Alert: Soleno Therapeutics, Inc. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Hyperphagia Drug Launch Disruptions - Hagens Berman

BioMarin Announces Board Leadership Transition

Collaboration Connects Early Autism Diagnosis with High-Quality, Outcomes-Driven Care Amid Industry-Wide Access Issues

Jazz Pharmaceuticals to Report First Quarter Financial Results on May 5, 2026

Dignity Health Champions Sustainability Across California

Target Hospitality Announces Launch of Secondary Offering

Inhibrx Provides Clinical Update on Ozekibart (INBRX-109) in Late Line Colorectal Cancer

TransMedics to Report First Quarter 2026 Financial Results on May 5, 2026

ISCT Announces Inaugural CGT Clinical Applications Program for Clinical Fellows